還有更多這樣的題目挑戰 ›

階段 5 — 採取行動。排列 DKA 治療計畫的主要決策點，從初始治療到轉換。指定的監測、檢驗和誘因評估任務持續並行進行。

Ordered Response

選擇作答後，查看答案。

After DKA resolution and when oral intake is feasible, give the planned basal-bolus insulin with at least 1 to 2 hours of overlap before stopping IV insulin DKA 緩解且可進食時，在停止靜脈胰島素前給予計畫的基礎-餐時胰島素，並至少重疊 1 至 2 小時

Begin prescribed isotonic saline or balanced crystalloid to restore perfusion, individualizing the initial and subsequent rates to the clinical response 開始醫囑的等張生理食鹽水或平衡晶體溶液以恢復灌注，根據臨床反應個別化初始和後續速率

Verify serum potassium and renal or urine-output status; if potassium is below 3.5 mmol/L, replace potassium and delay insulin until it rises 確認血清鉀離子和腎臟或尿量狀態；若鉀離子低於 3.5 mmol/L，先補充鉀離子並延遲胰島素直到上升

Start prescribed IV regular insulin when potassium is above 3.5 mmol/L and continue serial glucose, potassium, beta-hydroxybutyrate, and acid-base monitoring 當鉀離子高於 3.5 mmol/L 時，開始醫囑的靜脈常規胰島素，並持續監測血糖、鉀離子、β-羥基丁酸和酸鹼狀態

When glucose falls below 250 mg/dL, add 5 to 10 percent dextrose and adjust insulin so treatment can continue until ketonemia and acidosis resolve 當血糖降至 250 mg/dL 以下時，加入 5% 至 10% 葡萄糖並調整胰島素，以便治療可持續至酮血症和酸中毒緩解

查看答案

相同主題的下一題Stage 2 — Analyze cues. For each finding, select the single role it plays in the current D…本題收錄於此題庫[전통+신유형] NCLEX LEVEL UP 패키지KRW 79,000

僅供學習參考。實際臨床請遵循最新指引與所屬機構規範。